Collectively, these findings imply that ADAMTS4 SNPs could affect the expression and function of ADAMTS4 and ultimately increase HCC risk and shorten the prognosis of patients with this cancer. This evidence concerns the gene ADAMTS4 and hepatocellular carcinoma.